Katherine Y. FuRoxana ZamudioJo Henderson-FrostAlex Almuedo-RieraHannah SteinbergSteven J. ClipmanGustavo DuranRachel MarcusThomas CrawfordDaniel Alyesh2026-03-222026-03-22201710.1590/0037-8682-0015-2017https://doi.org/10.1590/0037-8682-0015-2017https://andeanlibrary.org/handle/123456789/49064Citaciones: 8Caspase-1 polymorphisms may play a role in Chagas cardiomyopathy development and could serve as markers to identify individuals at higher risk for priority treatment.enChagas diseaseCardiomyopathySingle-nucleotide polymorphismGenotypeOdds ratioMedicineInternal medicineImmunologyBiologyarticle